Hemophilia B Global Clinical Trials Review, H2, 2016

Publisher Name :
Date: 31-Aug-2016
No. of pages: 129
Inquire Before Buying

GlobalData's clinical trial report, "Hemophilia B Global Clinical Trials Review, H2, 2016" provides an overview of Hemophilia B clinical trials scenario. This report provides top line data relating to the clinical trials on Hemophilia B. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope


  • The report provides a snapshot of the global clinical trials landscape

  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

  • The Report provides enrollment trends for the past five years

  • Report provides latest news for the past three months


Reasons to buy


  • Assists in formulating key business strategies with regards to investment

  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost

  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

  • Supports understanding of trials count and enrollment trends by country in global therapeutics market

  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Hemophilia B Global Clinical Trials Review, H2, 2016

Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Five Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Hemophilia B to Hematological Disorders Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Hemophilia B to Hematological Disorders Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Hemophilia B Therapeutics Clinical Trials 27
Prominent Drugs 29
Latest Clinical Trials News on Hemophilia B 30
Sep 07, 2016: Catalyst Biosciences to Focus on Improved Factor IX Clinical Hemostasis Program 30
Jul 26, 2016: CSL Behring Presents Phase III Data for IDELVION for Hemophilia B at the World Federation of Hemophilia 2016 World Congress 30
Jul 25, 2016: Alnylam Announces New Positive Interim Phase 1 Study Results for Fitusiran, a Once-Monthly, Subcutaneous, Investigational RNAi Therapeutic Targeting Antithrombin for the Treatment of Hemophilia and Rare Bleeding Disorders 31
Jul 25, 2016: Alnylam to Report New Clinical Results with Fitusiran at the World Federation of Hemophilia 2016 World Congress 33
Jul 19, 2016: CSL Behring to Present New Data for IDELVION at the World Federation of Hemophilia 2016 World Congress 33
Jul 18, 2016: Biogen and Sobi to Showcase Long-Term Efficacy and Safety Data on ALPROLIX at World Federation of Hemophilia 2016 World Congress 34
Clinical Trial Profile Snapshots 35
Appendix 126
Abbreviations 126
Definitions 126
Research Methodology 127
Secondary Research 127
About GlobalData 128
Contact Us 128
Disclaimer 128
Source 129

List of Tables

Hemophilia B Therapeutics, Global, Clinical Trials by Region, 2016* 6
Hemophilia B Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Hemophilia B Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Hemophilia B Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
Hemophilia B Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Hemophilia B Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Hemophilia B Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 12
Hemophilia B Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 13
Proportion of Hemophilia B to Hematological Disorders Clinical Trials, G7 Countries (%), 2016* 14
Hemophilia B Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Hemophilia B Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Hemophilia B to Hematological Disorders Clinical Trials, E7 Countries (%), 2016* 17
Hemophilia B Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Hemophilia B Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Hemophilia B Therapeutics, Global, Clinical Trials by Phase, 2016* 20
Hemophilia B Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
Hemophilia B Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Hemophilia B Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Hemophilia B Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Hemophilia B Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25
Hemophilia B Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Hemophilia B Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28
Hemophilia B Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29

List of Figures

Hemophilia B Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Hemophilia B Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Hemophilia B Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Hemophilia B Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
Hemophilia B Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
Hemophilia B Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
Hemophilia B Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 12
Hemophilia B Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 13
Proportion of Hemophilia B to Hematological Disorders Clinical Trials, G7 Countries (%), 2016* 14
Hemophilia B Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Hemophilia B Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Hemophilia B to Hematological Disorders Clinical Trials, E7 Countries (%), 2016* 17
Hemophilia B Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Hemophilia B Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Hemophilia B Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20
Hemophilia B Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21
Hemophilia B Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Hemophilia B Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Hemophilia B Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Hemophilia B Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25
Hemophilia B Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Hemophilia B Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Hemophilia B Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29
GlobalData Methodology 127

  • Global Clinical Trial Management System (CTMS) Market 2017-2021
    Published: 06-Nov-2017        Price: US 3500 Onwards        Pages: 84
    Clinical trials are defined as research studies undertaken to successfully test a drug or a medical device before launching the product in the market. These studies are pivotal as the data generated in these studies forms the basis for the approval process of a drug or a medical device. Typically, these clinical trials are divided into five phases with each phase as critical as any other. It takes approximately 12 years to successfully complete a clinical trial, and the typical cost estimate ......
  • Global Clinical Trial Supplies Market Size, Status and Forecast 2022
    Published: 05-Oct-2017        Price: US 3300 Onwards        Pages: 94
    This report studies the global Clinical Trial Supplies market, analyzes and researches the Clinical Trial Supplies development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Alamc Group - Catalent Pharma Solutions - KLIFO A/S - Movianto - PCI Services - Patheon - PAREXEL International - Sharp Packaging Services - Biocair - Thermo......
  • Hyperalgesia Global Clinical Trials Review, H2, 2017
    Published: 27-Sep-2017        Price: US 2500 Onwards        Pages: 99
    Hyperalgesia Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hyperalgesia Global Clinical Trials Review, H2, 2017" provides an overview of Hyperalgesia clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperalgesia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trial......
  • Hyperammonemia Global Clinical Trials Review, H2, 2017
    Published: 27-Sep-2017        Price: US 2500 Onwards        Pages: 43
    Hyperammonemia Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hyperammonemia Global Clinical Trials Review, H2, 2017" provides an overview of Hyperammonemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperammonemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinic......
  • Hyperandrogenism Global Clinical Trials Review, H2, 2017
    Published: 27-Sep-2017        Price: US 2500 Onwards        Pages: 78
    Hyperandrogenism Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hyperandrogenism Global Clinical Trials Review, H2, 2017" provides an overview of Hyperandrogenism clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperandrogenism. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of diseas......
  • Hyperbilirubinemia Global Clinical Trials Review, H2, 2017
    Published: 27-Sep-2017        Price: US 2500 Onwards        Pages: 59
    Hyperbilirubinemia Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hyperbilirubinemia Global Clinical Trials Review, H2, 2017" provides an overview of Hyperbilirubinemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperbilirubinemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage o......
  • Hypercalcemia Global Clinical Trials Review, H2, 2017
    Published: 27-Sep-2017        Price: US 2500 Onwards        Pages: 60
    Hypercalcemia Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hypercalcemia Global Clinical Trials Review, H2, 2017" provides an overview of Hypercalcemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hypercalcemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical t......
  • Hyperinsulinemia Global Clinical Trials Review, H2, 2017
    Published: 27-Sep-2017        Price: US 2500 Onwards        Pages: 69
    Hyperinsulinemia Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hyperinsulinemia Global Clinical Trials Review, H2, 2017" provides an overview of Hyperinsulinemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperinsulinemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of diseas......
  • Hypercholesterolemia Global Clinical Trials Review, H2, 2017
    Published: 27-Sep-2017        Price: US 2500 Onwards        Pages: 770
    Hypercholesterolemia Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hypercholesterolemia Global Clinical Trials Review, H2, 2017" provides an overview of Hypercholesterolemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hypercholesterolemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers co......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs